LivFul

The company develops health solutions intended to advance health equity in the global south and health abundance worldwide.

LivFul, a medical venture based in the Liverpool city region, receives US regulatory approval for its insect repellent. This marks a significant milestone for the company’s expansion plans and commercial potential. The approval opens doors for broader market access in the United States, a key growth opportunity for LivFul’s product line.

Sep 2026Liverpool Business NewsNews article

LivFul expands its insect repellent product, FEND, into over 1,000 retail stores across Australia and New Zealand. New pharmacy listings include Chempro, Blooms, Ramsay, and Discount Chemist Outlet, all major retailers in the region. The partnership strengthens LivFul’s market presence in the southern hemisphere.

Oct 2025STAYTECNews article

LivFul Innovation establishes a regional hub in Liverpool to advance its insect repellent designed to combat malaria, a disease responsible for nearly 600,000 deaths annually. The product targets mosquito-borne transmission, a critical health challenge in affected regions. The company’s move aims to scale operations and potentially expand its impact in public health.

Apr 2025Liverpool Business NewsNews article

Hogan Bassey leverages biotechnology at LivFul to detect and prevent treatable diseases. The company focuses on early intervention strategies to improve health outcomes globally. LivFul’s approach combines scientific innovation with a mission-driven ethos to address preventable illnesses.

Dec 2016Black EnterpriseNews article